High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models

Overview of attention for article published in Cell, September 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 8 public wall posts from 8 users.

科學家發現中和新冠病毒的抗體根據發表在《細胞》(Cell) 期刊的研究，美國匹茲堡大學開發了一種可中和新冠病毒的最小生物分子，經過測試能有效預防和治療小鼠與倉鼠的新冠肺炎感染，此抗體已被用於製造Ab8藥物，該藥不會與人體細胞結合，表示不會對人體產生副作用…

Article in the current issue of Cell: High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal…

Se necesitan con urgencia nuevas terapias COVID-19. Generamos una biblioteca de dominios VH de anticuerpos humanos mostrada en…

High potency of a bivalent human VH domain in SARS-CoV-2 animal models.

High potency of a bivalent human VH domain reported in SARS-CoV-2 animal models. https://bit.ly/2RwCOL2

Ralph S. Baric is a co-author on a potentially interesting therapy. https://www.cell.com/cell/pdf/S0092-8674(20)31148-X.pdf

Could be a COVID breakthrough. https://www.cell.com/cell/fulltext/S0092-8674(20)31148-X?fbclid=IwAR3O_Zn7OXqQJbxMhh3yVrB2yz-waa…

Científicos de la Facultad de Medicina de la Universidad de Pittsburgh han aislado una molécula biológica más pequeña que "neutra…